Articles tagged with Bipolar Disorder
Researchers at the University of Cincinnati have been approved for PCORI funding to implement healthy lifestyle interventions and metformin prescription to manage weight gain in SGA-treated youth. The project aims to increase the number of youth with overweight/obesity who are offered metformin and healthy lifestyle education.
A comprehensive review of bipolar disorder treatments has been published, identifying the most effective treatments across different age groups and mood phases. The review has been used to update clinical guidelines and provides a platform for clinicians and patients to make informed treatment decisions based on the latest evidence.
Researchers at Salk Institute create a body-wide single-cell atlas of two major epigenetic systems, revealing that cell-type-specific epigenetic features can affect disease risk. The study identifies over 1.36 million differentially methylated regions and 283,606 differential chromatin loops across the human body's cell types.
A study published in PLOS Medicine found that people with dementia, mild cognitive impairment, alcohol addiction, or psychiatric disorders like schizophrenia show increased brain aging patterns. The researchers analyzed MRI data from over 45,900 controls and compared them to 2,698 patients with different brain conditions.
A new study found that adults with disabilities have more than three times the rate of alcohol use disorder diagnoses compared to adults without disabilities in the US. Adults with serious mental illness and acquired brain injuries had the highest rates of AUD, with men with disabilities having the highest rates.
A new scanning technique has shown that lithium levels in the brain and blood are closely matched across the day, regardless of dosing regimen. This finding could lead to more personalized treatment options for patients with bipolar disorder.
A USC study found subtle but widespread differences in the brain's communication networks in people with bipolar disorder, relating these differences to illness severity and treatment. The research team analyzed brain scans from 449 individuals with bipolar disorder and 510 healthy controls, revealing less densely connected networks an...
Researchers at UCLA Health have identified a brain region called the ventromedial prefrontal cortex (vmPFC) that regulates memory integration. The vmPFC acts as a quality control checkpoint, preventing memories from getting mixed up when they are significantly different or far apart in time.
A study links insulin resistance and leptin dysregulation to cognitive impairment in bipolar disorder, highlighting the potential of targeted clinical pathways. Metabolic alterations are associated with cognitive deficits and poorer performance in memory and attention.
A new study reveals that electroconvulsive therapy (ECT) can lead to significant negative impacts on standard of living, personal relationships, and even brain damage. Relatives and friends of ECT patients report long-term effects including memory loss, emotional blunting, and loss of independence.
A systematic review of social media platforms reveals that TikTok contains a substantial proportion of misleading information about mental health and neurodivergence, with higher rates of misinformation than other platforms. The study emphasizes the importance of credible sources and evidence-based content to combat spreading false ide...
Dr. Phillips's laboratory identifies abnormalities in prefrontal-striatal-limbic circuitry as biomarkers for bipolar disorder before symptoms appear. Her team tracks neural network development from infancy through young adulthood.
Emerging research across conceptual frameworks, biomarker science, digital phenotyping, and artificial intelligence synthesizes a translational pathway toward a more biologically grounded and clinically useful approach to psychiatric diagnosis. The current system falls short due to standardized clinical language and lack of biological ...
A study of over 1 million diagnosed individuals reveals genetic links between 14 psychiatric conditions, grouping them into five major factors. The findings may facilitate future treatments and drug repurposing, with potential applications in schizophrenia and substance abuse
A massive Swedish study of over 2 million individuals reveals that genetic risk for mental illness is far less disorder-specific than clinicians have assumed. Schizophrenia shows the highest genetic specificity, while drug use disorder has a much lower specificity, scattering its genetic risk across multiple conditions.
A pilot clinical trial suggests that low-dose oral lithium may help slow the decline of verbal memory in older adults with mild cognitive impairment, particularly those with evidence of amyloid beta. The study found that participants receiving lithium showed a slower rate of decline on a sensitive test of verbal memory.
A cohort study found that adolescent cannabis use is associated with an increased risk of developing psychiatric disorders, particularly psychotic and bipolar conditions. The study's results inform the development of interventions and policies to prevent or delay adolescent cannabis use.
A Swedish study of prematurely born adults found increased morbidity in physical and mental health, yet they reported a high quality of life. The study, which followed participants from birth to age 26-29, suggests that premature birth does not necessarily limit daily life.
The study reveals that the paraventricular thalamic nucleus (PVT) is the central pathological substrate of bipolar disorder, with notable alterations in cell number and gene expression. This discovery highlights the PVT as a potential diagnostic and therapeutic target for improving patient outcomes.
The study found that mania accounts for more than 80% of the genetic variation in bipolar disorder. The researchers identified 71 genetic variants linked specifically to mania, including 18 regions of genes that had never previously been associated with bipolar disorder.
A recent study published in PLOS Medicine found that individuals who received emergency or hospital care for hallucinogen use are at a higher risk of developing mania and bipolar disorder. The study revealed a six-fold increased risk of mania diagnosis within three years for those who received such care.
A major meta-analysis found that nitrous oxide can offer fast-acting depressive symptom relief for adults with major depressive disorder and treatment-resistant depression. The study showed significant improvements in mood within 24 hours, but repeated dosing over several weeks was needed to sustain clinical benefit.
A study published in The Lancet Psychiatry found that metformin can help manage weight gain in overweight or obese youth taking medication for bipolar disorder, making it a potential standard of care treatment. The MOBILITY trial showed modest but significant benefits of metformin over no treatment, with well-tolerated side effects.
The study identified dozens of genetic regions that influence the size and thickness of the corpus callosum and its subregions. The research team created an AI-powered tool that finds and measures the corpus callosum in brain MRI scans automatically, allowing for unprecedented analysis of brain structure at scale and precision.
A University of Minnesota Medical School research team, led by Ziad Nahas, has been awarded a $4.4 million grant to explore how large-scale brain networks regulate mood in bipolar disorder. The team will test a novel type of brain stimulation called Personalized and Adaptive Cortico Electrostimulation (PACE) to relieve symptoms and ide...
The Mount Sinai team will investigate neural mechanisms underlying bipolar disorder and pioneer novel neuromodulation-based treatment strategies.
International Consortium of Women's Mental Health Experts recommend classifying postpartum psychosis as a distinct category within standardized medical coding systems. This classification is crucial for improving patient outcomes and saving lives, particularly due to the risks associated with the condition to both patients and infants.
A new study from Karolinska Institutet and UCL found that living in a safe neighborhood with high personal trust reduces psychosis risk among Swedish or European origin residents, but increases it for North African or Middle Eastern origin individuals. The researchers emphasize the need for inclusive environments to promote mental heal...
Researchers from the University of South Australia explore the connection between the gut and brain to decipher their role in mental health and wellbeing. The study found that changes in the gut microbiome can directly affect brain chemistry, suggesting a potential link between gut health and mental illness.
A renowned geneticist, Dr. Martin Alda, has made a groundbreaking discovery that bipolar disorder is composed of multiple genetically distinct disorders, transforming treatment approaches worldwide. His research also highlights the importance of combining basic research with clinical observations to advance psychiatric care.
Research in African populations aims to understand the link between depression and hypertension, two conditions affecting millions worldwide. The study will focus on identifying shared genetic mechanisms, which could lead to more effective treatment strategies for complex diseases.
Johns Hopkins researchers used machine learning to analyze electric activity of mini-brains grown in a lab, revealing unique firing patterns associated with schizophrenia and bipolar disorder. The study improves accuracy in distinguishing between healthy and unhealthy brain organoids, paving the way for potential diagnostic tests and p...
Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) has announced a fourth round of Discovery Research funding for bipolar disorder. The program aims to support groundbreaking research into the genetic, molecular, cellular, circuit, and behavioral mechanisms of the disorder.
Research finds that bipolar disorder is associated with neurodegenerative protein accumulation and tau pathology in the paraventricular thalamus, potentially contributing to its symptoms. The study also identifies a new marker, CHMP2B-positive granulovacuolar degeneration, in about half of BD cases.
The study found sex differences in age at diagnosis, treatment onset, illness duration, illicit drug use, and smoking among individuals with bipolar disorder and schizophrenia. Females showed better functioning and neurocognitive performance than males, while males had higher rates of substance use.
Professor Gregor Hasler's pioneering research reveals how psychedelics like LSD, psilocybin, and MDMA enhance neuroplasticity, allowing the brain to rewire itself and break free from depression, PTSD, and addiction. His discoveries have the potential to fundamentally alter international approaches to mental health treatment.
Preliminary findings suggest that neuroimaging and mobile sensing can identify neural and behavioral markers of bipolar disorder and mood recurrence. Dr. Danella Hafeman's research uses fMRI and mobile sensing to detect early indicators of depressive and manic symptoms.
Researchers have found subtle abnormalities in heart muscle function and blood pumping in young adults with bipolar disorder before the onset of heart failure. The study suggests a link between underlying coronary vascular dysfunction and cardiac impairment.
A large international real-world data study found that antidepressant use does not significantly increase the risk of manic episodes in patients with bipolar depression. The study analyzed data from 122,843 outpatients and employed propensity score matching to control for confounding factors.
A wearable sensor could revolutionize lithium monitoring for people with bipolar disorder by tracking medication levels through sweat. The USC-made device, which is the first of its kind, eliminates the need for blood draws and offers a personalized and easily accessible monitoring system.
The BD² Integrated Network, a collaborative research model, aims to improve care and outcomes for people with bipolar disorder. The Ottawa Hospital Research Institute will receive $2.3 million to join the network, accelerating recruitment and advancing discovery.
Dr. Mirko Manchia's groundbreaking research identifies genetic markers predicting treatment response in bipolar patients, enabling precision medicine approaches to transform psychiatric care. He envisions a future where genetic testing becomes routine in psychiatric care.
A new systematic review reveals a significant connection between the gut microbiome and brain function in bipolar patients, affecting treatment responses. Patients who responded to treatment had distinct gut microbiome profiles similar to healthy individuals.
Researchers at Harvard University's Wyss Institute have successfully created human microglia cells in a dish, using induced pluripotent stem cells, within four days. This breakthrough enables new avenues for brain disease-focused research and potential therapeutic perspectives.
Professor Benedetti's research explores the intersection of genetics, environmental factors, and treatment response in mood disorders. His work has led to breakthroughs in chronotherapeutics and immuno-psychiatry, revealing crucial insights into immune-inflammatory mechanisms and gene variants influencing brain function.
A comprehensive review reveals that early ECT sessions show substantial improvement, but subsequent sessions may lead to diminishing returns and cognitive side effects. The researchers propose a response-guided sequential treatment strategy, categorizing patients into three groups based on their response patterns.
Research found that women whose sister experienced postpartum psychosis are over 10 times more likely to experience it themselves. The study highlights genetic and shared environmental influences and suggests early recognition and prevention are crucial.
Researchers found that specific combinations of personality traits can predict bipolar disorder outcomes, with certain styles raising and others lowering the risk of depression. The study used data from over 2,500 people with bipolar disorder and suggests a personalized approach to treatment planning.
Scientists at deCODE genetics identified associations between rare loss-of-function variants in HECTD2 and AKAP11 genes and the risk of bipolar disorder. The study suggests that these gene products may be promising targets for new treatments, as they interact with key cellular pathways involved in the disorder.
The BD² Integrated Network, a collaborative model connecting bipolar disorder research and care, has expanded to 10 sites with four new institutions joining the network. The model combines traditional longitudinal cohort study and learning health network to improve outcomes for people with bipolar disorder.
Researchers from Aarhus University found a machine-learning algorithm that can predict patients with high risk of developing schizophrenia or bipolar disorder within the next five years. The study analyzed electronic health record data and identified key factors, including words describing symptoms in clinical notes.
Heavy screen use, particularly social media and video games, is associated with an increased risk of developing manic symptoms in U.S. preteens. The study found that prolonged screen time can lead to behaviors characteristic of bipolar-spectrum disorders, including inflated self-esteem, decreased sleep needs, and impulsivity.
Researchers used machine learning to predict diagnostic transition to schizophrenia and bipolar disorder, with schizophrenia being notably easier to forecast. By analyzing routine clinical data, the study suggests a possible approach for early intervention and personalized treatment plans.
A new study published in Brain Medicine reveals that over 26.7% of schizophrenia patients experience distinct manic symptoms, which can be predicted by the severity of positive symptoms such as hallucinations and delusions.
A pilot study will explore whether a ketogenic diet helps stabilize mood symptoms in teens and young adults with bipolar disorder. Preliminary research suggests improvements in mood and executive function among older adults.
Research by Professor Stephen M. Stahl suggests that Jackson Pollock incorporated images into his pre-drip paintings, possibly due to spatial skills linked to bipolar disorder. The same images appear in multiple drip paintings, implying a deliberate encoding of images.
Researchers at McGill University discovered a novel brain mechanism that explains why bipolar patients alternate between mania and depression. A dopamine-based 'second brain clock' controls mood shifts, operating in tandem with the body's natural sleep-wake cycle.
Researchers used fitness tracker data and machine learning to detect bipolar disorder mood swings with 80.1% accuracy for depression and 89.1% accuracy for mania. The study's findings move the field toward personalized algorithms suitable for all patients, regardless of compliance or device access.
Leila Nabulsi is expanding her research program to pinpoint brain pathways affected by bipolar disorder. She will leverage the ENIGMA consortium and advanced statistical methods to build a database of brain changes, potentially improving diagnosis and treatment.
A study published in JAMA Psychiatry found a significant association between genetic predisposition and sexual trauma with increased risk for schizophrenia, bipolar disorder, and major depression. The research highlights the importance of considering social and environmental factors in human genetics studies.